Sean Davis

42.0k citations
94 papers · 18.3k indexed · 6 hit papers · h-index 47

Sean Davis

90 papers receiving 18.1k citations

Hit Papers

Integ...2420052026201220192.0k4.0k6.0k

Peers

Sean Davis
Comparison fields: 5 of 176
  • Cancer Research 3.9k
  • Molecular Biology 12.2k
  • Immunology 2.3k
  • Oncology 2.4k
  • Pulmonary and Respiratory Medicine 2.8k
Replace Helga Thorvaldsdóttir with:
Helga Thorvaldsdóttir United States
David Lyon United States
Bruce J. Aronow United States
Stefan Wyder Switzerland
Annika L. Gable Switzerland
Jerry Pelletier Canada
Arthur Liberzon United States
Alberto Santos Denmark
Ge Gao China
W. Evan Johnson United States
Sean Davis relative to Helga Thorvaldsdóttir United States Helga Thorvaldsdóttir's profile →
Citations per field
00.5×1.6×
Helga Thorvaldsdóttir · 1×
Citations per year

Countries citing papers authored by Sean Davis

Since Specialization
Citations

This map shows the geographic impact of Sean Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Davis more than expected).

Fields of papers citing papers by Sean Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Davis. The network helps show where Sean Davis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sean Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sean Davis Line = papers co-authored together Sean Davis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 201977
3 201761
4 20164
5 2015271
6 201465
7 2013204
8 201320
9 201276
10 201225
11 201048
12 201081
13 200936
14 200847
15 200728
16 2005277
17 2005102
18 2005368
19 20041
20 200015

About Sean Davis

Sean Davis is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 94 papers that have together received 18.3k indexed citations. Recurring topics across this work include Gene expression and cancer classification (14 papers), Genomics and Chromatin Dynamics (11 papers), Cancer Genomics and Diagnostics (10 papers), Genomic variations and chromosomal abnormalities (9 papers), Bioinformatics and Genomic Networks (9 papers), Epigenetics and DNA Methylation (7 papers), RNA Research and Splicing (7 papers) and Genomics and Phylogenetic Studies (6 papers). The work is most often cited by research in Cancer Research (3.9k citations), Molecular Biology (12.2k citations) and Immunology (2.3k citations). Sean Davis has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Paul S. Meltzer, Carlos Evangelista, Hyeseung Lee, Michelle Holko, Tanya Barrett, Katherine Phillippy, Kimberly A. Marshall, Naigong Zhang, Pierre Ledoux and Irene F. Kim. Their work appears in journals such as Cancer Research, PLoS ONE, Genome Research, Oncogene and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026